SD-970

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSD-970
Drug Alias NameDeuterium-substituted ticagrelor
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAuspex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAuspex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAcute Coronary Syndrome

Other Information

ATC CodeN/A
Related LinksN/A